Ra Pharmaceuticals, Inc.. (RARX) NASDAQ
$48 - (-)
Market Cap: $2.26B
As of 04/01/20 12:00 AM EDT. Market closed.
Ra Pharmaceuticals, Inc.. (RARX)
NASDAQ
$48
- (-)
Market Cap: $2.26B
As of 04/01/20 12:00 AM EDT. Market closed.
Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, ... read more
Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Treco Douglas A | President and CEO | Apr 02, 2020 | Option Exercise | $48.00 | 234,707 | 11,265,936 | 0 | Apr 03, 2020, 09:02 AM |
Lubner David Charles | Executive VP and CFO | Apr 02, 2020 | Option Exercise | $48.00 | 15,622 | 749,856 | 0 | Apr 03, 2020, 09:02 AM |
Ricardo Alonso | See Remarks | Apr 02, 2020 | Option Exercise | $48.00 | 2,973 | 142,704 | 0 | Apr 03, 2020, 09:02 AM |
Read Simon | Chief Scientific Officer | Apr 02, 2020 | Option Exercise | $48.00 | 12,595 | 604,560 | 0 | Apr 03, 2020, 09:02 AM |
Farzaneh-Far Ramin | Chief Medical Officer | Apr 02, 2020 | Option Exercise | $48.00 | 14,492 | 695,616 | 0 | Apr 03, 2020, 09:01 AM |
King John C | Chief Commercial Officer | Apr 02, 2020 | Option Exercise | $48.00 | 10,823 | 519,504 | 0 | Apr 03, 2020, 09:01 AM |
Shah Rajeev M. | Director | Apr 02, 2020 | Option Exercise | $48.00 | 4,858,260 | 233,196,480 | 0 | Apr 03, 2020, 09:00 AM |
RA CAPITAL MANAGEMENT, L.P. | Director | Apr 02, 2020 | Option Exercise | $48.00 | 4,858,260 | 233,196,480 | 0 | Apr 03, 2020, 12:00 AM |
Ricardo Alonso | See Remarks | Mar 17, 2020 | Sale | $44.25 | 2,288 | 101,244 | 0 | Mar 18, 2020, 06:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Mar 16, 2020 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Mar 18, 2020, 06:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Mar 16, 2020 | Sale | $45.16 | 10,595 | 478,521 | 7,132 | Mar 18, 2020, 06:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Feb 18, 2020 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Feb 20, 2020, 06:52 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Feb 18, 2020 | Sale | $46.61 | 10,595 | 493,850 | 7,132 | Feb 20, 2020, 06:52 PM |
Ricardo Alonso | See Remarks | Jan 17, 2020 | Sale | $47.02 | 2,285 | 107,441 | 2,288 | Jan 21, 2020, 06:32 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jan 15, 2020 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Jan 16, 2020, 06:01 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jan 15, 2020 | Sale | $46.95 | 10,595 | 497,441 | 7,132 | Jan 16, 2020, 06:01 PM |
Ricardo Alonso | See Remarks | Dec 17, 2019 | Sale | $47.08 | 2,285 | 107,568 | 4,573 | Dec 18, 2019, 06:01 PM |
Read Simon | Chief Scientific Officer | Dec 17, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Dec 18, 2019, 06:01 PM |
Read Simon | Chief Scientific Officer | Dec 17, 2019 | Sale | $47.08 | 10,000 | 470,821 | 6,234 | Dec 18, 2019, 06:01 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Dec 16, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Dec 18, 2019, 06:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Dec 16, 2019 | Sale | $47.23 | 10,595 | 500,351 | 7,132 | Dec 18, 2019, 06:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Nov 15, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Nov 18, 2019, 05:08 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Nov 15, 2019 | Sale | $46.66 | 10,595 | 494,319 | 7,132 | Nov 18, 2019, 05:08 PM |
Read Simon | Chief Scientific Officer | Nov 14, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Nov 18, 2019, 05:07 PM |
Read Simon | Chief Scientific Officer | Nov 14, 2019 | Sale | $46.68 | 10,000 | 466,808 | 6,234 | Nov 18, 2019, 05:07 PM |
Ricardo Alonso | See Remarks | Oct 17, 2019 | Sale | $46.70 | 2,285 | 106,710 | 6,858 | Oct 17, 2019, 08:11 PM |
Read Simon | Chief Scientific Officer | Oct 16, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Oct 17, 2019, 07:00 PM |
Read Simon | Chief Scientific Officer | Oct 16, 2019 | Sale | $46.87 | 10,000 | 468,726 | 6,234 | Oct 17, 2019, 07:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Oct 15, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Oct 17, 2019, 07:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Oct 15, 2019 | Sale | $46.89 | 10,595 | 496,769 | 7,132 | Oct 17, 2019, 07:00 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Sep 16, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Sep 16, 2019, 06:44 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Sep 16, 2019 | Sale | $25.26 | 10,595 | 267,675 | 7,132 | Sep 16, 2019, 06:44 PM |
Read Simon | Chief Scientific Officer | Sep 12, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Sep 16, 2019, 06:43 PM |
Read Simon | Chief Scientific Officer | Sep 12, 2019 | Sale | $25.41 | 10,000 | 254,050 | 6,234 | Sep 16, 2019, 06:43 PM |
Read Simon | Chief Scientific Officer | Aug 23, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Aug 27, 2019, 06:01 PM |
Read Simon | Chief Scientific Officer | Aug 23, 2019 | Sale | $27.77 | 10,000 | 277,703 | 6,234 | Aug 27, 2019, 06:01 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Aug 23, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Aug 27, 2019, 06:01 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Aug 23, 2019 | Sale | $27.77 | 10,595 | 294,226 | 7,132 | Aug 27, 2019, 06:01 PM |
Ricardo Alonso | See Remarks | Aug 23, 2019 | Sale | $27.89 | 2,285 | 63,740 | 9,143 | Aug 27, 2019, 06:00 PM |
Read Simon | Chief Scientific Officer | Jul 17, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Jul 18, 2019, 07:04 PM |
Read Simon | Chief Scientific Officer | Jul 17, 2019 | Sale | $32.95 | 10,000 | 329,479 | 6,234 | Jul 18, 2019, 07:04 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jul 15, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Jul 16, 2019, 07:15 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jul 15, 2019 | Sale | $33.10 | 10,595 | 350,647 | 11,348 | Jul 16, 2019, 07:15 PM |
Ricardo Alonso | See Remarks | Jun 21, 2019 | Sale | $23.72 | 2,857 | 67,782 | 11,428 | Jun 25, 2019, 04:16 PM |
Read Simon | Chief Scientific Officer | Jun 18, 2019 | Option Exercise | $2.87 | 10,000 | 28,700 | 16,234 | Jun 19, 2019, 09:03 PM |
Read Simon | Chief Scientific Officer | Jun 18, 2019 | Sale | $22.25 | 10,000 | 222,467 | 6,648 | Jun 19, 2019, 09:03 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jun 17, 2019 | Option Exercise | $5.60 | 10,595 | 59,332 | 17,727 | Jun 19, 2019, 09:03 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Jun 17, 2019 | Sale | $21.84 | 10,595 | 231,384 | 14,316 | Jun 19, 2019, 09:03 PM |
King John C | Chief Commercial Officer | Apr 16, 2019 | Option Exercise | $21.93 | 4,506 | 98,817 | 10,823 | Apr 18, 2019, 05:55 PM |
Lubner David Charles | Executive V.P. & CFO | Feb 01, 2019 | Option Exercise | $21.00 | 3,291 | 69,111 | 7,126 | Feb 05, 2019, 07:39 PM |
Read Simon | Chief Scientific Officer | Feb 01, 2019 | Option Exercise | $21.00 | 2,933 | 61,593 | 6,234 | Feb 05, 2019, 07:39 PM |
Farzaneh-Far Ramin | Chief Medical Officer | Feb 01, 2019 | Option Exercise | $21.00 | 3,285 | 68,985 | 7,132 | Feb 05, 2019, 07:38 PM |
Treco Douglas A | President and CEO | Feb 01, 2019 | Option Exercise | $21.00 | 6,327 | 132,867 | 218,799 | Feb 05, 2019, 07:38 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Dec 14, 2018 | Buy | $15.50 | 645,161 | 9,999,996 | 6,135,234 | Dec 14, 2018, 06:22 PM |
RA CAPITAL MANAGEMENT, LLC | Director | Dec 12, 2018 | Buy | $15.50 | 1,006,452 | 15,600,006 | 4,858,260 | Dec 14, 2018, 06:17 PM |
Shah Rajeev M. | Director | Dec 14, 2018 | Buy | $15.50 | 1,006,452 | 15,600,006 | 4,858,260 | Dec 14, 2018, 06:14 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Feb 16, 2018 | Buy | $6.00 | 2,000,000 | 12,000,000 | 5,490,073 | Feb 21, 2018, 04:19 PM |
Shah Rajeev M. | Director | Feb 14, 2018 | Buy | $6.00 | 2,500,000 | 15,000,000 | 3,851,808 | Feb 16, 2018, 04:42 PM |
RA CAPITAL MANAGEMENT, LLC | Director | Feb 14, 2018 | Buy | $6.00 | 2,500,000 | 15,000,000 | 3,851,808 | Feb 16, 2018, 04:42 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 19, 2017 | Sale | $22.02 | 3,220 | 70,899 | 2,251,457 | Jun 20, 2017, 04:41 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 16, 2017 | Sale | $21.24 | 53,200 | 1,130,207 | 2,254,677 | Jun 20, 2017, 04:41 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 08, 2017 | Sale | $22.00 | 700 | 15,400 | 2,307,877 | Jun 12, 2017, 04:12 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 07, 2017 | Sale | $22.11 | 4,840 | 106,999 | 2,308,577 | Jun 08, 2017, 04:33 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 06, 2017 | Sale | $22.98 | 7,274 | 167,161 | 2,313,417 | Jun 08, 2017, 04:33 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 05, 2017 | Sale | $23.11 | 4,780 | 110,488 | 2,320,691 | Jun 06, 2017, 04:27 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 02, 2017 | Sale | $23.47 | 14,867 | 348,949 | 2,325,471 | Jun 06, 2017, 04:27 PM |
Novartis Bioventures Ltd | 10% Owner | Jun 01, 2017 | Sale | $23.89 | 10,722 | 256,176 | 2,340,338 | Jun 02, 2017, 04:25 PM |
Novartis Bioventures Ltd | 10% Owner | May 31, 2017 | Sale | $23.94 | 35,539 | 850,896 | 2,351,060 | Jun 02, 2017, 04:25 PM |
Novartis Bioventures Ltd | 10% Owner | May 25, 2017 | Sale | $25.00 | 53 | 1,325 | 2,391,899 | May 30, 2017, 04:29 PM |
Novartis Bioventures Ltd | 10% Owner | May 26, 2017 | Sale | $25.14 | 5,300 | 133,267 | 2,386,599 | May 30, 2017, 04:29 PM |
Novartis Bioventures Ltd | 10% Owner | May 24, 2017 | Sale | $25.01 | 17,451 | 436,364 | 2,391,952 | May 25, 2017, 04:57 PM |
Novartis Bioventures Ltd | 10% Owner | May 18, 2017 | Sale | $25.50 | 9,019 | 229,964 | 2,409,403 | May 22, 2017, 06:50 PM |
Novartis Bioventures Ltd | 10% Owner | May 17, 2017 | Sale | $25.51 | 22,534 | 574,901 | 2,418,422 | May 18, 2017, 04:36 PM |
Novartis Bioventures Ltd | 10% Owner | May 16, 2017 | Sale | $26.33 | 20,081 | 528,725 | 2,440,956 | May 18, 2017, 04:36 PM |
Novartis Bioventures Ltd | 10% Owner | Feb 28, 2017 | Sale | $20.86 | 7,847 | 163,670 | 2,468,815 | May 02, 2017, 05:22 PM |
Novartis Bioventures Ltd | 10% Owner | Feb 27, 2017 | Sale | $20.96 | 57,844 | 1,212,306 | 2,476,662 | May 02, 2017, 05:22 PM |
Novartis Bioventures Ltd | 10% Owner | Feb 24, 2017 | Sale | $20.93 | 5,398 | 113,000 | 2,534,506 | May 02, 2017, 05:22 PM |
Novartis Bioventures Ltd | 10% Owner | Feb 23, 2017 | Sale | $21.04 | 4,999 | 105,160 | 2,539,904 | May 02, 2017, 05:22 PM |
Novartis Bioventures Ltd | 10% Owner | Feb 22, 2017 | Sale | $21.86 | 749 | 16,370 | 2,544,903 | May 02, 2017, 05:22 PM |
Novartis Bioventures Ltd | 10% Owner | Mar 01, 2017 | Sale | $20.91 | 7,778 | 162,658 | 2,461,037 | May 02, 2017, 05:22 PM |
Novo A/S | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 246,154 | 3,200,002 | 2,031,562 | Nov 02, 2016, 04:54 PM |
Shah Rajeev M. | Director | Oct 31, 2016 | Buy | $13.00 | 161,538 | 2,099,994 | 1,351,808 | Oct 31, 2016, 08:46 PM |
RA CAPITAL MANAGEMENT, LLC | Director | Oct 31, 2016 | Buy | $13.00 | 161,538 | 2,099,994 | 1,351,808 | Oct 31, 2016, 07:41 PM |
Weller Harry R | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:52 PM |
Weller Harry R | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:52 PM |
Weller Harry R | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:52 PM |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 263,538 | 3,425,994 | 2,745,846 | Oct 31, 2016, 04:51 PM |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 340 | 4,420 | 79,821 | Oct 31, 2016, 04:51 PM |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 63,019 | 4,411 | 80,161 | Oct 31, 2016, 04:51 PM |
Viswanathan Ravi | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:51 PM |
Viswanathan Ravi | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:51 PM |
Viswanathan Ravi | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:51 PM |
SANDELL SCOTT D | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:51 PM |
SANDELL SCOTT D | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:51 PM |
SANDELL SCOTT D | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:51 PM |
Lettmann Jason | Director | Oct 31, 2016 | Buy | $13.00 | 393,923 | 5,120,999 | 4,066,503 | Oct 31, 2016, 04:51 PM |
Lettmann Jason | Director | Oct 31, 2016 | Sale | $13.00 | 340 | 4,420 | 79,821 | Oct 31, 2016, 04:51 PM |
Lettmann Jason | Director | Oct 31, 2016 | Option Exercise | $0.07 | 63,019 | 4,411 | 80,161 | Oct 31, 2016, 04:51 PM |
MOTT DAVID M | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:51 PM |
MOTT DAVID M | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:51 PM |
MOTT DAVID M | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:51 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:50 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:50 PM |
KOLLURI KRISHNA KITTU | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:50 PM |
Novartis Bioventures Ltd | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 84,615 | 1,099,995 | 2,545,652 | Oct 31, 2016, 04:50 PM |
Novartis Bioventures Ltd | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 339 | 4,407 | 62,575 | Oct 31, 2016, 04:50 PM |
Novartis Bioventures Ltd | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 62,914 | 4,404 | 62,914 | Oct 31, 2016, 04:50 PM |
KERINS PATRICK J | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:50 PM |
KERINS PATRICK J | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:50 PM |
KERINS PATRICK J | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:50 PM |
BASKETT FOREST | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:49 PM |
BASKETT FOREST | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:49 PM |
BASKETT FOREST | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:49 PM |
BARRIS PETER J | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:49 PM |
BARRIS PETER J | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:49 PM |
BARRIS PETER J | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:49 PM |
BARRETT M JAMES | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:48 PM |
BARRETT M JAMES | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:48 PM |
BARRETT M JAMES | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:48 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 31, 2016 | Buy | $13.00 | 338,462 | 4,400,006 | 3,490,073 | Oct 31, 2016, 04:48 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 31, 2016 | Sale | $13.00 | 435 | 5,655 | 80,223 | Oct 31, 2016, 04:48 PM |
NEW ENTERPRISE ASSOCIATES 13 LP | 10% Owner | Oct 31, 2016 | Option Exercise | $0.07 | 80,658 | 5,646 | 80,658 | Oct 31, 2016, 04:48 PM |